Astellas Pharma, Inc. (ALPMF)
15.85
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Astellas Pharma Max Drawdown (5Y) : 43.93% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 43.93% |
| June 30, 2026 | 43.93% |
| May 31, 2026 | 43.93% |
| April 30, 2026 | 43.93% |
| March 31, 2026 | 43.93% |
| February 28, 2026 | 43.93% |
| January 31, 2026 | 43.93% |
| December 31, 2025 | 43.93% |
| November 30, 2025 | 43.93% |
| October 31, 2025 | 43.93% |
| September 30, 2025 | 43.93% |
| August 31, 2025 | 43.93% |
| July 31, 2025 | 43.93% |
| June 30, 2025 | 43.93% |
| May 31, 2025 | 43.93% |
| April 30, 2025 | 43.93% |
| March 31, 2025 | 43.93% |
| February 28, 2025 | 43.93% |
| January 31, 2025 | 43.93% |
| December 31, 2024 | 43.93% |
| November 30, 2024 | 43.93% |
| October 31, 2024 | 43.93% |
| September 30, 2024 | 43.93% |
| August 31, 2024 | 43.93% |
| July 31, 2024 | 43.93% |
| Date | Value |
|---|---|
| June 30, 2024 | 43.93% |
| May 31, 2024 | 43.93% |
| April 30, 2024 | 43.93% |
| March 31, 2024 | 36.92% |
| February 29, 2024 | 71.57% |
| January 31, 2024 | 73.37% |
| December 31, 2023 | 75.40% |
| November 30, 2023 | 75.40% |
| October 31, 2023 | 75.40% |
| September 30, 2023 | 75.40% |
| August 31, 2023 | 75.40% |
| July 31, 2023 | 75.40% |
| June 30, 2023 | 75.40% |
| May 31, 2023 | 75.40% |
| April 30, 2023 | 75.40% |
| March 31, 2023 | 75.40% |
| February 28, 2023 | 75.40% |
| January 31, 2023 | 75.55% |
| December 31, 2022 | 76.62% |
| November 30, 2022 | 76.62% |
| October 31, 2022 | 76.62% |
| September 30, 2022 | 76.62% |
| August 31, 2022 | 76.74% |
| July 31, 2022 | 77.04% |
| June 30, 2022 | 78.19% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Daiichi Sankyo Co., Ltd. | 64.07% |
| Takeda Pharmaceutical Co., Ltd. | 50.60% |
| Eisai Co., Ltd. | 95.02% |
| Chugai Pharmaceutical Co., Ltd. | 59.68% |
| Santen Pharmaceutical Co., Ltd. | 69.08% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -1.318 |
| Beta (5Y) | -0.0059 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 27.63% |
| Historical Sharpe Ratio (5Y) | -0.0497 |
| Historical Sortino (5Y) | -0.0942 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 11.64% |